Back to Search Start Over

Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of EnterobacteralesExpressing Extended-Spectrum β-Lactamases and Serine Carbapenemases

Authors :
Chatwin, Cassandra L.
Hamrick, Jodie C.
Trout, Robert E. L.
Myers, Cullen L.
Cusick, Susan M.
Weiss, William J.
Pulse, Mark E.
Xerri, Luigi
Burns, Christopher J.
Moeck, Gregory
Daigle, Denis M.
John, Kaitlyn
Uehara, Tsuyoshi
Pevear, Daniel C.
Source :
Antimicrobial Agents and Chemotherapy; July 2021, Vol. 65 Issue: 8
Publication Year :
2021

Abstract

There is an urgent need for oral agents to combat resistant Gram-negative pathogens. Here, we describe the characterization of VNRX-5236, a broad-spectrum boronic acid β-lactamase inhibitor (BLI), and its orally bioavailable etzadroxil prodrug, VNRX-7145.

Details

Language :
English
ISSN :
00664804 and 10986596
Volume :
65
Issue :
8
Database :
Supplemental Index
Journal :
Antimicrobial Agents and Chemotherapy
Publication Type :
Periodical
Accession number :
ejs57064044
Full Text :
https://doi.org/10.1128/AAC.00552-21